Maine Medical Center Research Institute, Center for Outcomes Research and Evaluation
Large-panel genomic tumor testing (GTT) is a new technology that promises to make cancer treatment more precise, but that currently poses many uncertainties regarding its clinical value and appropriate use. Uncertainty Tolerance (UT), a psychological construct that describes trait-level differences in individuals’ responses to uncertainty, may influence oncologists’ perceptions and attitudes regarding GTT.
Anderson, Eric; Hinton, Alexandra; Lary, Christine; Murray, Kimberly; Waterson, Leo; Han, Paul; and Maine Cancer Genomics Initiative, "The relationship between uncertainty tolerance and oncologists’ perceptions of large-panel genomic tumor testing" (2019). Maine Medical Center. 692.